To treat or not treat with statins patients with chronic heart failure?

Abstract

Rosuvastatin provides clinical benefic in patients with relatively low concentrations of natriuretic peptides, while it has no clinical effect in patients with high natriuretic peptide concentrations. Similarly, rosuvastatin provides clinical benefic in patients with high hs-CRP but hass no effect in patientswith normal hs-CRP.

Keywords

• CORONA study
• GISSI-HF trial
• rosuvastatin
• chronic heart failure
• hsCRP
• natriuretic peptides